Portola Pharmaceuticals, Inc. Variable Interest Entity, Initial Consolidation, Gain (Loss)
Portola Pharmaceuticals, Inc. reported Variable Interest Entity, Initial Consolidation, Gain (Loss) of $2.93 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableInterestEntityInitialConsolidationGainOrLoss · last filed 2018-03-01
- Portola Pharmaceuticals, Inc. variable interest entity, initial consolidation, gain (loss) for fiscal 2015 was $2.93M.
| Period end | Variable Interest Entity, Initial Consolidation, Gain (Loss) 12 month |
|---|---|
| 2015-12-31 | $2.93M 10-K · filed 2018-03-01 |